0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
31 Ansichten4 Seiten
The anaesthetist plays an important role in the multidisciplinary team management of patients with major burns which should occur in specialised regional units. Burns have a direct local effect on blood vessel integrity and function. There are also widespread effects on capillary permeability and blood flow.
The anaesthetist plays an important role in the multidisciplinary team management of patients with major burns which should occur in specialised regional units. Burns have a direct local effect on blood vessel integrity and function. There are also widespread effects on capillary permeability and blood flow.
The anaesthetist plays an important role in the multidisciplinary team management of patients with major burns which should occur in specialised regional units. Burns have a direct local effect on blood vessel integrity and function. There are also widespread effects on capillary permeability and blood flow.
multidisciplinary team management of patients with major burns which should occur in spe- cialised regional units. All anaesthetists need to be familiar with the principles of anaesthesia for these patients as they may be required to care for a major burn in an emergency or to provide care for minor burns outside the regional centres. Initial resuscitation and stabilisation has already been covered previously in this journal (see key refer- ences). This article deals with the preparation of burns patients for theatre and peri-operative anaes- thetic management. Pathophysiological changes Airway The upper airway may be compromised. Acutely, thermal injury leads to progressive swelling of the soft tissues and potential airway obstruction. This swelling may persist for several days and may be complicated by scarring and contractures. The lower airway is rarely burned by exposure to heat unless substances with a very high specific heat capacity are inhaled, such as superheated steam. The lower airway is injured by inhalation of smoke, leading to inflammation, mucosal slough- ing, airway irritability and activation of the sys- temic inflammatory response syndrome (SIRS). The acute consequences of this in severe smoke inhalation include development of excess pul- monary secretions, bronchospasm and the acute respiratory distress syndrome (ARDS). The constituents of the smoke also determine the degree of airway injury and consequent hyp- oxaemia. For example, products of combustion of certain household commodities such as PVC, Teflon and polyurethane are particularly toxic as they contain chemicals such as hydrogen chlo- ride, phosgene, hydrogen cyanide and isocyanate. In addition to the hypoxaemia resulting from air- way damage, many of these compounds have toxic effects on the cellular respiratory chain, fur- ther aggravating the hypoxaemia. Even when the effects have resolved, increased airway reactivity may persist for several months after the injury. Circulation Burns have a direct local effect on blood vessel integrity and function; there are also widespread effects on capillary permeability and blood flow. In the area of full thickness burns, vessels will be thrombosed or destroyed. There is a localised increase in tissue capillary permeability as a direct result of thermal injury. In addition, activa- tion of the systemic inflammatory response caus- es a widespread increase in vascular permeability with generalised oedema. Mediators involved in the vascular response to burn injury include hist- amine, prostaglandins PGE 2 and PGI 2 , leuko- trienes LB 4 and LD 2 , thromboxane A 2 , inter- leukin-6, catecholamines, oxygen free radicals, platelet aggregation factor, angiotensin II and vasopressin. Although bradykinin and serotonin levels are increased in the immediate post-burn period, their antagonists have not been demon- strated to reduce consequent oedema. Inhalation injury, hypo-albuminaemia and sepsis exacerbate this increase in vascular permeability. Patients require fluid resuscitation to allow for these loss- es but invariably, in the early stages after the burn, patients have relative hypovolaemia and decreased tissue perfusion. Later, the patient develops a cardiovascular picture of high cardiac output and vasodilatation due to sepsis or SIRS. As a result of the cardiovascular changes, there may be impaired renal perfusion and function. Muscle The muscle underlying any burn may be dam- aged, but this is much more likely following elec- trocution which may cause myoglobin release and further renal damage. More widespread Anaesthetic management for burns patients Roland G Black MRCP FRCA John Kinsella FRCA British Journal of Anaesthesia | CEPD Reviews | Volume 1 Number 6 2001 The Board of Management and Trustees of the British Journal of Anaesthesia 2001 Key points Anaesthesia is required on numerous occasions following a major burn Anaesthetists play a major role in resuscita- tion, intensive care and analgesia Sepsis, systemic inflam- matory response syn- drome, altered pharma- cokinetic compartments and receptor population changes make response to drugs unpredictable Hyperkalaemia following succinylcholine, resis- tance to non-depolarising muscle relaxants and air- way compromise lead to difficulty with airway management Vascular access, pro- longed procedures, blood loss and temperature homeostasis are major challenges Roland G Black MRCP FRCA Clinical Research Fellow University Department of Anaesthesia Glasgow Royal Infirmary 10 Alexandra Parade Glasgow G31 2ER John Kinsella FRCA Consultant in Anaesthesia and Intensive Care University Department of Anaesthesia Glasgow Royal Infirmary 10 Alexandra Parade Glasgow G31 2ER Anaesthetic management for burns patients 178 British Journal of Anaesthesia | CEPD Reviews | Volume 1 Number 6 2001 muscle conformational changes gradually develop after injury with proliferation of acetylcholine receptors which has conse- quences for neuromuscular junction function. Myocardial depression occurs as a result of circulating factors which have been shown to have direct negative inotropic effects on in vitro myocardial preparations. The exact mechanism of action is unknown, but free radical scavengers such as super-oxide dismu- tase have been shown to increase myocardial contractility follow- ing burn injury, suggesting oxygen free radicals may play a role. Following an electrical burn, cardiac muscle may be damaged, increasing the risk of myocardial dysfunction and dysrhythmias. Pharmacology Large fluid shifts, changes in compartment sizes and increase in metabolic rate alter the pharmacokinetics of many drugs. Low albumin leads to an increased free fraction of acidic drugs such as sulphonylureas or anticonvulsants. Raised fibrinogen and 1 acid glycoprotein will reduce the free fraction of basic drugs (e.g. local anaesthetics, propranolol and muscle relaxants). As most laborato- ries measure total drug concentrations rather than free fractions, serum concentrations may be misleading. These effects, in combi- nation with altered receptor populations and pharmacodynamics, significantly alter the dose requirements and effects of many anaesthetic drugs. Requirements for anaesthesia The anaesthetist has a number of skills that may be required in the care of the burn patient. In the initial resuscitation, airway assess- ment, intubation, vascular access, fluid resuscitation, administra- tion of analgesia and intensive care may all be required. General anaesthesia may be required for intubation, emergency tracheosto- my, escharotomy and urgent surgery for other injuries. There is an increasing trend towards early definitive surgery to the burn wound, both as a means of improving cosmetic result and as a way of removing necrotic tissue, thereby reducing the on- going stimulus for SIRS. As a consequence, patients may require anaesthesia as soon as they are fully resuscitated. From this point, the patient may require multiple procedures over many days and weeks. Subsequently, reconstructive surgery may be performed over several years. Choice of agents Induction and maintenance of anaesthesia Ketamine 12 mg kg 1 has traditionally been advocated as the induction anaesthetic of choice. The combination of its analgesic effects, sympathetic stimulation and maintenance of airway reflex- es would seem to make it the ideal agent. However, it is associated with unpleasant emergence and, with the advent of shorter acting anaesthetics such as propofol, ketamine has been largely super- seded. Propofol 2 mg kg 1 with alfentanil 100 g kg 1 has been described as the induction dose of a TIVAtechnique. The choice of volatile agent does not seem to influence outcome from burns surgery. Analgesia Analgesic requirements in the initial phase vary. The patients per- ception of pain may be altered by reduced conscious level, alcohol, drugs, hypoxaemia or hypotension. The use of simple measures such as immobilisation, cooling or covering the burn may be effec- tive. Entonox can be used but only if the patients oxygen require- ments are less than 50%. Opioids are the mainstay of pain man- agement, but should be titrated intravenously rather than adminis- tered as boluses subcutaneously or intramuscularly (absorption from both of these routes is unpredictable). After the initial resuscitation phase, pain can be divided into background and procedural. The appropriate initial management of background pain should usually be with intravenous opioids. The successful use of opioid infusions and patient-controlled analgesia with morphine have been described in adults and children. Later, when feeding is established, background pain can be managed with oral analgesics. Again, requirements vary, so the doses should be titrated for each patient and, as tolerance develops quickly, dosing schedules should be reviewed regularly. Non-steroidal anti-inflam- matory drugs should be used with caution as these patients are already predisposed to renal dysfunction and gastric ulceration. The use of agonist-antagonist and partial agonist opioids has been described. However, their use has not become established because of limited efficacy and undesirable side effects. Procedural pain, such as that associated with debridement or with dressing changes, can be severe and require intravenous opi- oids. Again, dose requirements vary widely, depending on the indi- vidual and on factors such as position, extent and age of the burn and the presence or absence of local infection. Opioids should be titrated to effect. The use of a target-controlled infusion of alfen- tanil to provide analgesia for dressing changes has been described. In our study, high target concentrations (up to 290 ng ml 1 ) and total doses (up to 10.7 mg) of alfentanil were required; apnoea or desaturation did not occur. Neuromuscular blocking drugs The exaggerated hyperkalaemic response seen with succinyl- choline is thought to be due to extrajunctional migration of Anaesthetic management for burns patients British Journal of Anaesthesia | CEPD Reviews | Volume 1 Number 6 2001 179 acetylcholine receptors. The earliest described post-burn hyper- kalaemic response is at 9 days and the earliest cardiac arrest at 21 days. The exaggerated response persists for up to 10 weeks, though some argue that succinylcholine should be avoided for 1 year post- injury. Burns patients also demonstrate a resistance to non-depolarising muscle blockade with the ED 50 of vecuronium in one study being 3 times that of controls. This resistance develops by 1 week and usually persists for 8 weeks; though resistance to metocurine has been described 463 days post-burn. It can only be partially explained by pharmacokinetic mechanisms; acetylcholine receptor proliferation may be responsible for some of this resistance. Other drugs Epinephrine solutions ranging in concentration from 1:1000 to 1:500,000 are applied topically or infiltrated subcutaneously to reduce blood loss at excision and donor sites. Resting plasma cat- echolamine concentrations are elevated post-burn, but the systemic absorption of epinephrine does not seem to be associated with sig- nificant cardiovascular side effects. Local anaesthetics applied topically are used for burn excision and donor site analgesia. The use of EMLA alone has been described for graft harvest in debilitated patients with burns of < 10% total body surface area. Lidocaine 2% sprayed onto the har- vest site has been shown to reduce opioid requirements in the 24 h post-surgery when compared with a placebo or 0.5% bupivacaine group. Toxic concentrations were not seen in either the lidocaine or bupivacaine group. Increased concentrations of 1 -acid glycopro- tein seen post-burn would be protective. Burns patients are particularly prone to infection due to the loss of the skins barrier function. Randomised controlled trials have failed to show any benefit of prophylactic antibiotics and their use merely promotes resistant strains of bacteria. Dose requirements of aminoglycosides, cephalosporins and -lactams are altered due to their increased clearance. Plasma concentrations should be moni- tored and doses adjusted accordingly. Monitoring Monitoring should routinely include ECG, arterial haemoglo- bin oxygen saturation, respiratory gas analysis, central tem- perature, urine output and blood pressure. Some of the diffi- culties relating to monitoring are summarised in Table 1. Pre-operative preparation and conduct of anaesthesia Fasting Burns patients are hypermetabolic. Repeated fasting required for surgical procedures may interfere with nutritional goals with associated increase in wound infection rate and muscle catabolism. It has been shown that patients only receive 15% of their nutritional needs on the day of surgery with a pre- operative fast of 4 h and 30% if the fasting time is reduced to 1 h. No aspiration was seen in either group suggesting that fasting guidelines should be modified in burns patients. Intubated patients can be fed intra-operatively. Transport to theatre There is considerable debate regarding the location of the theatre dealing with burns. A theatre in the burns unit minimizes patient transport distances, but has the risks associated with an isolated site. On the other hand, if surgery is taking place in the main theatre suite, there may be logistical issues concerning the Table 1 Problems encountered with routine monitoring in burns patients Monitor Difficulty in burns patients Potential solution ECG Gel electrodes may not pick up ECG through damaged skin Skin staples or subcutaneous needles attached to crocodile clips will give a good signal Lead placement, avoiding operative field Careful placement, avoiding areas to be debrided or harvest sites, e.g. limb leads SaO 2 Peripheral burns or vasoconstriction may lead to difficulty Use of alternate sites such as lips or tongue has been described with trace Carboxyhaemoglobin may give spurious results Use arterial gas analysis and carboxyhaemoglobin measurements if there is concern Blood pressure Invasive versus non invasive measurement Invasive blood pressure measurement carries the same risks as normal patients, siting of an arterial cannula may be difficult. However, waveform provides additional information and an arterial line facilitates arterial sampling End-tidal CO 2 Because of increased dead-space in inhalation injury, Arterial gas analysis should be used to monitor ventilatory settings end-tidal CO 2 may not reflect PaCO 2 CVP Access sites may be difficult Consider long lines Increased risk of infection and caval venous system thrombosis Needs to be balanced against the potential benefits Swan-Ganz As with CVP lines catheters Anaesthetic management for burns patients 180 British Journal of Anaesthesia | CEPD Reviews | Volume 1 Number 6 2001 transport of very unstable patients. Patients receiving inten- sive care should be transferred with full mobile facilities irre- spective of the location of the operating theatre. Airway Concerns about airway patency have been referred to above and should have been addressed at the initial resuscitation phase. However, oedema may be present even in the absence of overt airway injury. The anaesthetist should, therefore, be mindful of any airway compromise and, if there is any doubt, an awake fibre-optic intubation or gaseous induction should be carried out. Theoretically, because of the increased cardiac output occurring post-burn, a gas induction should take longer than usual. However, in practice, this is not seen. Intubation secures the airway and allows bronchoscopic evaluation of air- way injury. Patients already intubated should have the tube posi- tion checked and secured prior to the commencement of surgery. Concerns about airway patency in the later stages of burn injury are related to fibrosis and contractures making airway manipu- lation and intubation difficult or impossible. Fibre-optic intuba- tion may be required. The successful use of the laryngeal mask airway has been described in both adults and children. Patients with significant airway injury or a large burn will need artificial ventilation in theatre. They require a greater than normal minute volume as the basal metabolic rate is elevated and gas exchange may be compromised. Because of increased dead-space, end-tidal CO 2 measurements may not reflect arteri- al CO 2 tension and arterial gas analysis may be indicated. An intensive care ventilator may be required to deliver adequate minute ventilation and provide PEEP and advanced ventilatory modes. Following major burns, smoke inhalation and the subse- quent development of ARDS, these patients may be very depen- dent on PEEP. If there has been extensive blood loss and replacement, delayed extubation may be preferred. Fluid and temperature homeostasis Apatient should only be taken to theatre when fluid resuscitation is adequate (as evidenced by haemodynamic parameters and urine output) and in the absence of hypothermia. Wound debridement involves significant blood loss. It has been estimated that for every 1% body surface excised, 34% of the circulating blood volume may be lost. There should be adequate availability of red cells and clotting factors. Due to damage of the natural skin barrier, evapo- rative losses are raised, further increasing fluid requirements. Good wide bore i.v. access is essential. Depending on the size and posi- tion of the burn, traditional i.v. access sites may be unavailable and unusual peripheral venous sites or central venous access are fre- quently required. Care of the available veins is a priority and all i.v. access should be performed by experienced personnel. The combination of large fluid requirements and extensive patient exposure predisposes to intra-operative hypothermia which has undesirable effects on coagulation, cardiorespiratory function and drug handling. It has been shown to be associated with worse outcome in burns patients and should, therefore, be avoided. Central temperature should be measured and maintained and there should be adequate provision of warmed rapid infusion systems. If possible, forced warm air blankets should be used but these may be of limited efficacy due to the degree of patient exposure required. It is important that the theatre environment is at a ther- moneutral temperature (about 30C for these patients), although this may be uncomfortable for theatre staff. In the reconstructive phase of surgery, the viability of skin grafts and tissue flaps is improved if the patient is warm and hyperdy- namic. Careful attention should be paid to fluid status and mainte- nance of temperature using the measures outlined above. Patient position In both the acute and reconstructive phase of burn surgery, metic- ulous attention should be given to patient positioning as many procedures are prolonged. Patients are often required to be placed in the prone position or moved intra-operatively. Regional anaesthesia Despite being of use in minor burns, regional anaesthesia is not beneficial in major burns. The reasons for this are: (i) it can be difficult to block a sufficient area; (ii) vasodilatation associated with epidural blockade accentuates the hypotensive effects of blood loss during surgery; and (iii) the loss of the normal skin barrier leads to transient intra-operative bacteraemia which may colonise an epidural catheter. Key references Hilton PJ, Hepp M.The immediate care of the burned patient. BJA CEPD Rev 2001; 1: 1136 Judkins K. Burns treatment in the 21st century: a challenge for British anaes- thesia. Anaesthesia 1999; 54: 11315 Kinsella J, Rae C. Burn pain. Ballires Clin Anaesthesiol 1997; 11: 45972 Lingnau W, Woodson LC, Nichols RJ, Prough DS. Anaesthesia for burned patients. In: Herndon DN. (ed) Total Burn Care. London: Saunders, 1996; 14858 Whelan E. Drug disposition and action in the burned patient. Ballires Clin Anaesthesiol 1997; 11: 42740 Yowler CJ. Recent advances in burn care. Curr Opin Anaesth 2001; 14: 2515 See multiple choice questions 111113.